Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- The ex-dividend date for Novo Nordisk A/S (NYSE: NVO) is tomorrow, March 21, 2013. Owners of shares as of market close today will be eligible for a dividend of $2.32 per share. At a price of $167.11 as of 9:35 a.m. ET, the dividend yield is 1.4%. The average volume for Novo Nordisk A/S has been 339,900 shares per day over the past 30 days. Novo Nordisk A/S has a market cap of $93.21 billion and is part of the health care sector and drugs industry. Shares are up 2.2% year to date as of the close of trading on Tuesday. Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. The company has a P/E ratio of four, below the S&P 500 P/E ratio of 17.7.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.